Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
boston blog main
boston top stories
boulder/denver blog main
boulder/denver top stories
clinical trials
detroit blog main
detroit top stories
fda
4
×
indiana blog main
indiana top stories
life sciences
national
national blog main
national top stories
new york blog main
new york top stories
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
san francisco blog main
san francisco top stories
seattle blog main
seattle top stories
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
biotech
cancer
cancer immunotherapy
deals
investing
nonalcoholic steatohepatitis
startups
vertex pharmaceuticals
abbvie
astrazeneca
bristol-myers squibb
crispr therapeutics
What
drug
4
×
roundup
4
×
bio
annual
attention
biotech
fda
news
prices
ahead
alzheimer’s
ambien
american
approved
aren’t
asco
assessed
attendees
camp’s
cancer
cash
chicago
city
clinical
combinations
communities
community’s
companies
conference
days
developers
digital
disease
drugs
epidemic
esmo
europe
expanding
fatty
focus
Language
Current search:
fda
×
roundup
×
drug
×
@xconomy.com
5 years ago
Bio Roundup: NASH News, Merck Strikes, Digital Tokens & More
@xconomy.com
5 years ago
Bio Roundup: Alzheimer’s Puzzle, ESMO Assessed, Drug Prices & More
@xconomy.com
5 years ago
Bio Roundup: Medicare Drug Prices, FDA Moves, Gene Therapy News & More
@xconomy.com
5 years ago
Biotech Roundup: ASCO Ahead, CAMP4’s Cash, Ambien Tweeting & More
